Dr. Yingchao Zhao 赵迎超
Chief Physician, Associate Professor
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of cervical, ovarian, and endometrial cancers using radiotherapy, chemotherapy, molecular targeted therapy, immunotherapy, and international new drug clinical trials.
Dr. Zhao holds an MD and serves as Associate Chief of Gynecologic Oncology and Director of Ward II at Union Hospital. After two years at Harvard Medical School, Dr. Zhao has spent nearly 20 years in clinical practice, teaching, and research, focusing on radiotherapy, chemotherapy, and targeted therapies for gynecologic tumors.
Professional roles
- Member, Gynecologic Oncology Professional Committee, Chinese Society of Clinical Oncology (CSCO)
- Youth Committee Member, Chinese Society of Clinical Oncology (CSCO)
- Youth Committee Member, Radiotherapy Professional Committee, China Anti-Cancer Association (CACA)
- Member, Brachytherapy Group, Radiation Oncology Branch, Chinese Medical Doctor Association
Name order: in Chinese the family name comes first (Zhao Yingchao). Papers usually list the name as Yingchao Zhao or Zhao Y.
Selected publications
44 papers on PubMed matched by name and affiliation; 17 as first or senior author since 2016. Most recent first- or senior-author papers:
- MedComm (2020), 2026 (senior author): Concurrent Chemoradiotherapy Plus Immunotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer: A Randomized, Single-Center, Phase II Trial of Early Tumor Regression and Pro-Inflammatory Tumor Microenvironment Remodeling. PubMed 42428550
- Mol Cell Biochem, 2026 (senior author): Advancements in single-cell sequencing for cervical cancer research. PubMed 41199110
- J Obstet Gynaecol Res, 2025 (senior author): Global research trends and focus areas in gynecologic oncology education: A bibliometric and network visualization study. PubMed 41054973
- Chin Med J (Engl), 2025 (senior author): Radiotherapy and oncofertility: From physiological foundations to radiological perspectives. PubMed 39920898
- Int Immunopharmacol, 2024 (senior author): The role of BATF2 deficiency in immune microenvironment rearrangement in cervical cancer - New biomarker benefiting from combination of radiotherapy and immunotherapy. PubMed 37995570
- Hum Cell, 2023 (senior author): Insights into the characteristics of primary radioresistant cervical cancer using single-cell transcriptomics. PubMed 36867313
- Cancers (Basel), 2023 (senior author): Cancer-Associated Fibroblasts Exposed to High-Dose Ionizing Radiation Promote M2 Polarization of Macrophages, Which Induce Radiosensitivity in Cervical Cancer. PubMed 36900416
- Clin Transl Oncol, 2022 (senior author): Glycosylation and its research progress in endometrial cancer. PubMed 35752750
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion